HHS OIG: FDA Should Make Infant Formula Inspections Less Predictable

FDA should take formal steps to ensure that its infant formula facility inspections are not scheduled so predictably that plant operators can easily disguise issues, according to a new review by the HHS Office of the Inspector General that cites a former facility supervisor saying his facility was essentially turned into a “movie set” to hide issues from inspectors. In its report on issues that contributed to the infant formula shortage in 2022, the HHS OIG notes FDA has not...